Chronic pain and treatment-resistant depression — both impact millions of people, both can be debilitating and both can leave people feeling hopeless.

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

The first depression health economic modelling study, led by Professor Shirley Li Xue, from the LKS Faculty of Medicine, the ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Shields’s confession of postpartum depression reached an enormous audience, mainly because actor Tom Cruise publicly ...

Computer-assisted cognitive-behavior therapy (CCBT) and mobile mental health applications warrant continued development and ...

Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...